Dr. Edward Benz is the President and CEO Emeritus of Dana-Farber Cancer Institute, Director Emeritus and Principal Investigator of Dana-Farber/Harvard Cancer Center, and a member of the Governing Board of Dana-Farber/Children's Cancer Center. He is also a clinical hematologist and an active NIH-funded investigator. Dr. Benz is presently the Richard and Susan Smith Professor of Medicine, a Professor of Pediatrics, and a Professor of Genetics at the Harvard Medical School, where he received the Soma Weiss and Leon Resnick awards for research. He is a member of Phi Beta Kappa and Alpha Omega Alpha Honorific Societies.
Dr. Benz received an A.B., cum laude, from Princeton University, an M.D., magna cum laude, from Harvard Medical School, and an M.A. (privatum) from Yale University. Immediately prior to assuming the presidency of the Institute, Dr. Benz was Chairman of the Department of Medicine at the Johns Hopkins University School of Medicine and the Sir William Osler Professor of Medicine. Dr. Benz is a member of the Institute of Medicine of the National Academy of Sciences and the American Academy of Arts and Science. He is past President of the American Clinical and Climatological Association, the Association of American Cancer Institutes, American Society of Hematology (ASH), the American Society of Clinical Investigation and a previous co-chair of the NIH Advisory Board for its Clinical Research Center. Most recently, Dr. Benz received the annual Mentorship Award from the American Society of Hematology and the Margaret Kripke Legends in Medicine Award for Advancing the Careers of Women in Cancer Medicine. Dr. Benz is author of more than 200 articles, books, chapters, reviews, and abstracts, He is an associate editor of the New England Journal of Medicine and co-author of three textbooks, two of which have won international awards. Dr. Benz is an internist and an active NIH-funded investigator. He is an internationally recognized hematologist and an expert in inherited anemias and red cell diseases.